AMC Shares Surge as Macquarie Raises Price Target on Strong 2026 Box Office Outlook
Stronger theatrical recovery drives optimism despite lingering volatility.
Already have an account? Sign in.
Stronger theatrical recovery drives optimism despite lingering volatility.
BMO Capital gives Trevi Therapeutics an Outperform rating and $36 target, citing strong potential for Haduvio as a first-in-class treatment for chronic cough in idiopathic pulmonary fibrosis.
Analyst forecasts show Intel and Samsung struggling to close the gap on A16 and N2 technology.
Genuine Parts lowered its 2026 profit outlook amid weaker consumer demand. CEO Will Stengel denied rumors of a rival acquiring its automotive business.